Comparative Effect of High-Level Versus Low-Level Laser Therapy on Nerve Root Function Among Healthy Young Adults: A Randomized Controlled Trial

NCT ID: NCT07260994

Last Updated: 2025-12-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

58 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-11-24

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study title: Comparative Effect of High-Level Versus Low-Level Laser Therapy on Nerve Root Function Among Healthy Young Adults: A Randomized Controlled Trial You are invited to participate in a research study to investigate the short-term effect of high-intensity laser therapy (HILT), low-level laser therapy (LLLT), and sham laser on nerve root function among healthy adults.

Participation is entirely voluntary, and you may withdraw from the study at any time without penalty or need for justifications if you choose to do so.

What is the aim of the study? The objective of the current study is to investigate the short-term effect of high-intensity laser therapy (HILT), low-level laser therapy (LLLT), and sham laser on nerve root function among healthy adults.

Type of participants? We are recruiting participants aged 18-30 years of both genders without any musculoskeletal or neurological disorder involving the upper extremities, non-smokers, and if they expressed their wellness to participate in the current study.

What will participants be asked to do? The purpose of this study is to investigate the short-term effect of high-intensity laser therapy, low-level laser therapy, and sham laser on nerve root function among healthy adults.

If you agree to take part:

* First, we will check if you are eligible for the study.
* If you are eligible and give your consent, you will be randomly placed into one of three groups:

1. High-intensity laser therapy group
2. Low-level laser therapy group
3. Sham (placebo) group - in this group, the laser device will look and feel the same, but it will not actually deliver laser treatment.
* If you are in the sham group, you will not receive active laser therapy. This is important for the scientific accuracy of the study, as it allows us to compare the effects of real laser therapy with no treatment. You will not know which group you are in during the study, but you will be informed after your participation is complete.
* You will attend 9 short sessions over 3 weeks (3 sessions per week). Each session will last about 5-10 minutes.
* To measure nerve function before laser application (Step 1):

1. A small gel will be used to place two sensors on your head (these can be removed easily).
2. Three nerves in your arm will be tested using very light, safe electrical pulses delivered through a small hand-held electrode held in place with a strap.
3. This helps us measure how your nerves are working before laser treatment by measuring the peak-to-peak amplitude and latency of N20 point of the brain through analyzing the brain waves.
* Laser or sham application (Step 2):

1. A researcher will apply the laser (or sham) to three spots on your neck.
2. Each spot will receive laser for about 2 minutes.
3. The laser used is safe, does not cause heat, and you will not feel any burning.
* Measuring nerve function again (Step 3):

The same nerve test from step 1 will be repeated to see if there are any changes after the laser application.

* Men do not need to remove any clothing.
* Women who wear a headscarf will be asked to temporarily remove it so the head sensors can be placed. This will be done in a private room by a female researcher only, with doors locked and separators used to ensure complete privacy.
* Male participants will also be attended to by a male researcher in the same respectful and private way.
* It is very important to note that you may be assigned to a group where the laser is not actually turned on (sham group). This is important for the scientific accuracy of the study.
* You will be told which group you were in after the study is completed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
The study will be single-blind where the participants will be blinded to group assignments. While the primary investigator will be aware about the group assignment. Participants will be kept unaware about their group assignment, will be asked to complete a consent form explaining the study thoroughly, except the information related to the number of groups involved in the study, and will be provided by the additional information related to the group assignment after the completion of the study (Monaghan et al., 2021; Simon et al., 2021).

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HILT group

Participants in HILT group will receive laser therapy with a wavelength of 1064 nm, frequency of 25 Hz, output power of 7 W, and energy dose of 120 J/cm\^2, intervention will be delivered through non-contact mode, by using the Zimmer MedizinSysteme device (OptonPro, Germany) to deliver high-intensity laser over C6, C7, and C8 nerve roots as they exit the spinal column.

Group Type ACTIVE_COMPARATOR

High-intensity laser therapy

Intervention Type RADIATION

Participants in HILT group will receive laser therapy with a wavelength of 1064 nm, frequency of 25 Hz, output power of 7 W, and energy dose of 120 J/cm\^2, intervention will be delivered through non-contact mode, by using the Zimmer MedizinSysteme device (OptonPro, Germany) to deliver high-intensity laser over C6, C7, and C8 nerve roots as they exit the spinal column.

LLLT group

Participants in LLLT group will receive laser therapy with wavelength of 905nm, frequency of 5 kHz output power of 25mW, and energy dose of 2 J/cm\^2, intervention will be delivered through contact mode, by using the Enraf-Nonius Endolaser device (South Africa) to deliver low-level laser over C6, C7, and C8 nerve roots as the exit the spinal column.

Group Type ACTIVE_COMPARATOR

Low-level laser therapy

Intervention Type RADIATION

Participants in LLLT group will receive laser therapy with wavelength of 905nm, frequency of 5 kHz output power of 25mW, and energy dose of 2 J/cm\^2, intervention will be delivered through contact mode, by using the Enraf-Nonius Endolaser device (South Africa) to deliver low-level laser over C6, C7, and C8 as they exit the spinal column.

Sham laser group

For the participants in the sham group, the same procedure will be followed, but with having the laser device turned off.

Group Type SHAM_COMPARATOR

Sham laser

Intervention Type RADIATION

For the participants in the sham group, the same procedure will be followed, but with having the laser device turned off.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High-intensity laser therapy

Participants in HILT group will receive laser therapy with a wavelength of 1064 nm, frequency of 25 Hz, output power of 7 W, and energy dose of 120 J/cm\^2, intervention will be delivered through non-contact mode, by using the Zimmer MedizinSysteme device (OptonPro, Germany) to deliver high-intensity laser over C6, C7, and C8 nerve roots as they exit the spinal column.

Intervention Type RADIATION

Low-level laser therapy

Participants in LLLT group will receive laser therapy with wavelength of 905nm, frequency of 5 kHz output power of 25mW, and energy dose of 2 J/cm\^2, intervention will be delivered through contact mode, by using the Enraf-Nonius Endolaser device (South Africa) to deliver low-level laser over C6, C7, and C8 as they exit the spinal column.

Intervention Type RADIATION

Sham laser

For the participants in the sham group, the same procedure will be followed, but with having the laser device turned off.

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals deemed to be eligible to participate in the current study if they aged between 18 and 30 years of both genders, without any musculoskeletal or neurological disorder involving the upper extremities, non-smokers, and if they expressed their wellness to participate in the current study.

Exclusion Criteria

* Individuals will be excluded if they have a history of cervical spine disorders; significant cervical disc herniation, spinal narrowing, cervical nerve root compression, or cervical spinal cord dysfunction; a history of severe and frequent migraines, shoulder diseases, fibromyalgia, rheumatic or rheumatoid diseases, mental illnesses, severe osteoporosis, significant spinal deformities, or serious neurological, cardiovascular, or pulmonary conditions; the presence of fever, infection, tumors; cognitive or emotional disorders; or pregnant or nursing women (Xie et al., 2025).
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Sharjah

OTHER

Sponsor Role collaborator

Taif A. M. Omran

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Taif A. M. Omran

Master Student

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Taif Omran

Role: PRINCIPAL_INVESTIGATOR

University of Sharjah

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Sharjah

Sharjah city, , United Arab Emirates

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Arab Emirates

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Taif Omran

Role: CONTACT

+971551610573

Dr. Tamer Shousha, PhD

Role: CONTACT

+971562224469

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dr. Tamer Shousha, PhD

Role: primary

+97165057505

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC-25-06-24-03-PG

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.